{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:07:30Z","timestamp":1794377250243,"version":"4.9.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ymthe.2024.02.010","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T17:16:24Z","timestamp":1707498984000},"page":"969-981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Savannah M.","family":"Lawton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ni","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yen","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carley","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Vander Kooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6520-2373","authenticated-orcid":false,"given":"Carol H.","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.02.010_bib1","first-page":"s126","article-title":"Economic costs of hemophilia and the impact of prophylactic treatment on patient management","volume":"22","author":"Chen","year":"2016","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ymthe.2024.02.010_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3324\/haematol.2019.232132","article-title":"Hemophilia therapy: the future has begun","volume":"105","author":"Mannucci","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2024.02.010_bib3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa2002699","article-title":"BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A","volume":"383","author":"Konkle","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.02.010_bib4","first-page":"1109","article-title":"Model of Short- and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia A","volume":"26","author":"Zhou","year":"2020","journal-title":"J.\u00a0Manag. Care Spec. Pharm."},{"key":"10.1016\/j.ymthe.2024.02.010_bib5","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa2104205","article-title":"Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A","volume":"385","author":"George","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.02.010_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13023-022-02313-w","article-title":"Haemophilia gene therapy: experiences and lessons from treated patients","volume":"17","author":"Hermans","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2024.02.010_bib7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.addr.2008.03.005","article-title":"Microbubbles in ultrasound-triggered drug and gene delivery","volume":"60","author":"Hernot","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2024.02.010_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1517\/14712598.2016.1169268","article-title":"Prospect of ultrasound-mediated gene delivery in cardiovascular applications","volume":"16","author":"Chen","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.expneurol.2011.10.027","article-title":"Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption","volume":"233","author":"Huang","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2024.02.010_bib10","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.3892\/mmr.2015.4054","article-title":"Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)","volume":"12","author":"Wan","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2024.02.010_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2014.03.002","article-title":"Development of therapeutic microbubbles for enhancing ultrasound-mediated gene delivery","volume":"182","author":"Sun","year":"2014","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2024.02.010_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/gt.2008.51","article-title":"Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery","volume":"15","author":"Shen","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2018.04.012","article-title":"Prolonging pulse duration in ultrasound-mediated gene delivery lowers acoustic pressure threshold for efficient gene transfer to cells and small animals","volume":"279","author":"Tran","year":"2018","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2024.02.010_bib14","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/bloodadvances.2021006016","article-title":"Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression","volume":"6","author":"Manson","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.02.010_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2018.06.008","article-title":"Ultrasound-Mediated Gene Therapy in Swine Livers Using Single-Element, Multi-lensed, High-Intensity Ultrasound Transducers","volume":"10","author":"Noble-Vranish","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.010_bib16","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/mp300037t","article-title":"Efficient microbubble- and ultrasound-mediated plasmid DNA delivery into a specific rat liver lobe via a targeted injection and acoustic exposure using a novel ultrasound system","volume":"9","author":"Song","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2024.02.010_bib17","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.omtn.2022.01.006","article-title":"Ultrasound-mediated gene delivery of factor VIII plasmids for hemophilia A gene therapy in mice","volume":"27","author":"Song","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.02.010_bib18","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.1074\/jbc.273.19.11737","article-title":"The human ICAM-2 promoter is endothelial cell-specific in\u00a0vitro and in\u00a0vivo and contains critical Sp1 and GATA binding sites","volume":"273","author":"Cowan","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.02.010_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/nar\/gkv019","article-title":"A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells","volume":"43","author":"M\u00fcller-Kuller","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.02.010_bib20","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2003-10-3591","article-title":"Bioengineering of coagulation factor VIII for improved secretion","volume":"103","author":"Miao","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.010_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.omtm.2020.10.013","article-title":"Minimal Essential Human Factor VIII Alterations Enhance Secretion and Gene Therapy Efficiency","volume":"19","author":"Cao","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.010_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.64","article-title":"Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice","volume":"3","author":"Lange","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.010_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.02.010_bib24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/14712598.2022.2002842","article-title":"Hemophilia A gene therapy: current and next-generation approaches","volume":"22","author":"Pipe","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000720","article-title":"Gene Therapy for Hemophilia A: How Long Will It Last?","volume":"6","author":"Schutgens","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.ymthe.2024.02.010_bib26","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","article-title":"AAV5-Factor VIII Gene Transfer in Severe Hemophilia A","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.02.010_bib27","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/bloodadvances.2017009878","article-title":"Hemophilia gene therapy comes of age","volume":"1","author":"George","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.02.010_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.02.010_bib29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/mt.2015.135","article-title":"Hemophilia Gene Therapy: Caught Between a Cure and an Immune Response","volume":"23","author":"Herzog","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib30","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/j.ymthe.2022.10.004","article-title":"Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma","volume":"30","author":"Kapelanski-Lamoureux","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib32","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1016\/j.celrep.2018.08.049","article-title":"Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia","volume":"24","author":"An","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.02.010_bib33","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ymthe.2019.04.017","article-title":"mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency","volume":"27","author":"Cao","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.02.010_bib35","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1182\/blood-2014-02-554501","article-title":"Murine coagulation factor VIII is synthesized in endothelial cells","volume":"123","author":"Everett","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.010_bib36","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1182\/blood-2014-02-555151","article-title":"A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII","volume":"123","author":"Fahs","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.010_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-0037-1615880","article-title":"Animal testing of retroviral-mediated gene therapy for factor VIII deficiency","volume":"82","author":"Greengard","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2024.02.010_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2005-11-4532","article-title":"Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice","volume":"108","author":"Miao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.010_bib39","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-08-2954","article-title":"Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype","volume":"103","author":"Sarkar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.010_bib40","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1073\/pnas.96.18.10379","article-title":"Long-term expression of human coagulation factor VIII and correction of hemophilia A after in\u00a0vivo retroviral gene transfer in factor VIII-deficient mice","volume":"96","author":"VandenDriessche","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.02.010_bib41","first-page":"2086","article-title":"Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice","volume":"119","author":"Kren","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.02.010_bib42","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1634\/stemcells.2006-0699","article-title":"Ex\u00a0vivo gene therapy for hemophilia A that enhances safe delivery and sustained in\u00a0vivo factor VIII expression from lentivirally engineered endothelial progenitors","volume":"25","author":"Matsui","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2024.02.010_bib43","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1073\/pnas.0409249102","article-title":"Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy","volume":"102","author":"Xu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.02.010_bib44","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2009-02-202788","article-title":"The therapeutic effect of bone marrow-derived liver cells in the phenotypic correction of murine hemophilia A","volume":"114","author":"Yadav","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.010_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.36","article-title":"Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery","volume":"1","author":"Brown","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.010_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.56","article-title":"Effects of FVIII immunity on hepatocyte and hematopoietic stem cell-directed gene therapy of murine hemophilia A","volume":"3","author":"Lytle","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.010_bib47","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0037-1616143","article-title":"Tissue distribution of factor VIII gene expression in\u00a0vivo--a closer look","volume":"86","author":"Hollestelle","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2024.02.010_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jth.12412","article-title":"Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII","volume":"12","author":"Shahani","year":"2014","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2024.02.010_bib49","doi-asserted-by":"crossref","first-page":"19587","DOI":"10.1074\/jbc.274.28.19587","article-title":"Expression of factor VIII by murine liver sinusoidal endothelial cells","volume":"274","author":"Do","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.02.010_bib50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1182\/blood-2015-12-684688","article-title":"Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in\u00a0vivo","volume":"128","author":"Pan","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.010_bib51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/bloodadvances.2018027979","article-title":"FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice","volume":"3","author":"Merlin","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.02.010_bib52","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/bloodadvances.2020001468","article-title":"Unexpected enhancement of FVIII immunogenicity by endothelial expression in lentivirus-transduced and transgenic mice","volume":"4","author":"Shi","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.02.010_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/cmi.2016.5","article-title":"Immunological functions of liver sinusoidal endothelial cells","volume":"13","author":"Knolle","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2024.02.010_bib54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2024.02.010_bib55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41551-019-0445-9","article-title":"Antigen-specific immune tolerance in the liver","volume":"3","author":"Doherty","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"Suppl 5","key":"10.1016\/j.ymthe.2024.02.010_bib56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2516.2007.01574.x","article-title":"Inhibitors in haemophilia A: current management and open issues","volume":"13","author":"Haya","year":"2007","journal-title":"Haemophilia."},{"key":"10.1016\/j.ymthe.2024.02.010_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: Physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2024.02.010_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0065-2660(05)54007-0","article-title":"A novel gene expression system: non-viral gene transfer for hemophilia as model systems","volume":"54","author":"Miao","year":"2005","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ymthe.2024.02.010_bib59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1006\/mthe.2001.0333","article-title":"Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in\u00a0vivo","volume":"3","author":"Miao","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtm.2019.07.005","article-title":"Transcutaneous Ultrasound-Mediated Nonviral Gene Delivery to the Liver in a Porcine Model","volume":"14","author":"Tran","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.010_bib61","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/gt.2011.34","article-title":"Explorations of high-intensity therapeutic ultrasound and microbubble-mediated gene delivery in mouse liver","volume":"18","author":"Song","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymthe.2004.04.009","article-title":"Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice","volume":"10","author":"Ye","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.010_bib63","first-page":"612","article-title":"Proceedings: A more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb. Diath. Haemorrh."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T09:19:34Z","timestamp":1744449574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1525001624000790"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.02.010","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}